Back to search
Hereditary Spherocytosis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Hereditary Spherocytosis trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Hereditary Spherocytosis trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
INTEGRA aims at enabling personalized medicine for RHADs patients by the establishment of an integrative diagnostic approach based on deep phenotypic and geneti…
Human splenic physiology remains poorly understood due to lack of functional exploration. However, through its ability to recognize alterations or modifications…
Background : Patients with hereditary spherocytosis (HS) are characterized by increased red blood cell (RBC) fragility and a loss of RBC deformability. While th…
Patients with red blood cell disorders (RBCDs), such as Sickle cell disease (SCD) and Thalassemia, are chronic, life-threatening conditions that can become mult…